Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6647e12fda074f039ae079b15de63faa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6647e12fda074f039ae079b15de63faa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6647e12fda074f039ae079b15de63faa2021-12-02T15:08:22ZImproving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles10.1038/s41598-018-30834-72045-2322https://doaj.org/article/6647e12fda074f039ae079b15de63faa2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-30834-7https://doaj.org/toc/2045-2322Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM, may offer a novel therapeutic option for intraocular pressure control in glaucoma patients. For this purpose, targeted delivery of stem cells to the TM is desired. Here, we used magnetic nanoparticles (Prussian blue nanocubes [PBNCs]) to label mesenchymal stem cells and to magnetically steer them to the TM following injection into the eye’s anterior chamber. PBNC-labeled stem cells showed increased delivery to the TM vs. unlabeled cells after only 15-minute exposure to a magnetic field. Further, PBNC-labeled mesenchymal stem cells could be delivered to the entire circumference of the TM, which was not possible without magnetic steering. PBNCs did not affect mesenchymal stem cell viability or multipotency. We conclude that this labeling approach allows for targeted, relatively high-efficiency delivery of stem cells to the TM in clinically translatable time-scales, which are necessary steps towards regenerative medicine therapies for control of ocular hypertension in glaucoma patients.E. J. SniderK. P. KubelickK. TweedR. K. KimY. LiK. GaoA. T. ReadS. EmelianovC. R. EthierNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q E. J. Snider K. P. Kubelick K. Tweed R. K. Kim Y. Li K. Gao A. T. Read S. Emelianov C. R. Ethier Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
description |
Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM, may offer a novel therapeutic option for intraocular pressure control in glaucoma patients. For this purpose, targeted delivery of stem cells to the TM is desired. Here, we used magnetic nanoparticles (Prussian blue nanocubes [PBNCs]) to label mesenchymal stem cells and to magnetically steer them to the TM following injection into the eye’s anterior chamber. PBNC-labeled stem cells showed increased delivery to the TM vs. unlabeled cells after only 15-minute exposure to a magnetic field. Further, PBNC-labeled mesenchymal stem cells could be delivered to the entire circumference of the TM, which was not possible without magnetic steering. PBNCs did not affect mesenchymal stem cell viability or multipotency. We conclude that this labeling approach allows for targeted, relatively high-efficiency delivery of stem cells to the TM in clinically translatable time-scales, which are necessary steps towards regenerative medicine therapies for control of ocular hypertension in glaucoma patients. |
format |
article |
author |
E. J. Snider K. P. Kubelick K. Tweed R. K. Kim Y. Li K. Gao A. T. Read S. Emelianov C. R. Ethier |
author_facet |
E. J. Snider K. P. Kubelick K. Tweed R. K. Kim Y. Li K. Gao A. T. Read S. Emelianov C. R. Ethier |
author_sort |
E. J. Snider |
title |
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
title_short |
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
title_full |
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
title_fullStr |
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
title_full_unstemmed |
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles |
title_sort |
improving stem cell delivery to the trabecular meshwork using magnetic nanoparticles |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/6647e12fda074f039ae079b15de63faa |
work_keys_str_mv |
AT ejsnider improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT kpkubelick improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT ktweed improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT rkkim improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT yli improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT kgao improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT atread improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT semelianov improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles AT crethier improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles |
_version_ |
1718388189232627712 |